Alamar Biosciences Inc.
ALMR | NASDAQ
$29.17
-$1.43 (-4.67%)
Nov 2, 2026, 12:01 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
PE Ratio | -48.89 | n/a |
PEG Ratio | n/a | n/a |
PS Ratio | 19.72 | n/a |
PB Ratio | -9.21 | n/a |
P/FCF Ratio | -24.39 | n/a |
P/OCF Ratio | -27.30 | n/a |
OCF/S Ratio | -72.24 | n/a |
Debt / Equity Ratio | -0.26 | -0.25 |
Quick Ratio | 2.37 | 5.56 |
Current Ratio | 3.99 | 6.43 |
Asset Turnover | 0.53 | n/a |
Interest Coverage | -78.14 | n/a |
Return on Equity | 18.76% | n/a |
Return on Assets | -21.30% | n/a |
Return on Invested Capital | -26.47% | n/a |
Dividend Yield | n/a | n/a |
Payout Ratio | n/a | n/a |
FCF Payout Ratio | n/a | n/a |
Gross Profit Margin | 56.20% | n/a |
Net Profit Margin | -40.18% | n/a |
Pretax Profit Margin | -39.29% | n/a |
Operating Profit Margin | -42.22% | n/a |
FCF Margin | -80.84% | n/a |
EBITDA Margin | -33.54% | n/a |
Add to Watchlist
Select watchlists to add or remove ALMR